YD Bio Ltd YDES

Full chart Compare
Set alert

Price alert · YDES

All alert types
6.40 USD +0.42 (+7.12%)

At closeNov 3, 2026, 4:00 PM EST

6.40 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

5.81 Day range 6.48
1.70 52-week range 15.72
YTD
-47.54%
1 year
-43.56%
Market cap
452.97M
Revenue (ttm)
510.36K
Profit margin
-276.58%
EPS (ttm)
-0.04
Shares out
70.52M
YTD return
-47.54%
1-year return
-43.56%
Volume
23.34K
Avg volume
304.76K
Open
5.81
Previous close
5.97
Day's range
5.81 – 6.48
52-week range
1.70 – 15.72
Beta
0.16

2Y -7.06 (-52.84%)

1020Oct 25Jan 26Apr 26Jun 26Sep 266.30

Key statistics

Enterprise value
19.67M
PEG ratio
0.00
Price / sales
1829.50
Price / book
2.90
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
95.60%
Free cash flow
-3.88M
Total cash
3.13M
Total debt
22.27K
Return on equity
-42.69%
Short % of float
0.52%
50-day average
17.26
200-day average
17.26

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
YDES Revenue — quarterly 510.36K
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 2024
YDES Net income — quarterly 1.31M
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 2024
YDES EPS — quarterly 0.09
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 2024

About YD Bio Ltd

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Sector
Healthcare
Industry
Biotechnology
Country
Taiwan

News

Your note

Sign in to keep a note on YDES — it syncs with the Stock Master app.

Institution ownership

YDES institution ownership
Holder% heldSharesValueReported
Cerity Partners LLC0.05%32,406429.06KSep 29, 2025

Fund ownership

YDES fund ownership
Holder% heldSharesValueReported
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF0.03%20,862276.21KSep 29, 2025